IL22 and metabolic disease: ILC3-derived IL-22 are beneficial in metabolic syndrome (Wang et al., 2014; Zou et al., 2018) but can also contribute to metabolic disease (Sasaki et al., 2019; Upadhyay et al., 2012; Wang et al., 2017).